Clinical Trials List
2023-01-01 - 2029-05-19
Phase III
Recruiting7
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Shau-Hsuan Li Division of Hematology & Oncology
- 張育平 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
- 王逸熙 Division of Thoracic Medicine
- 林理涵 Division of Radiology
- 陳彥豪 Division of Hematology & Oncology
- 賴建豪 Division of Thoracic Medicine
- 李易濰 Division of Radiology
- 張晃智 Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
- 林孟志 Division of Thoracic Medicine
- 陳友木 Division of Thoracic Medicine
- 趙東瀛 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 郭家佑 Division of Thoracic Medicine
- 莊政皓 Division of Thoracic Medicine
- 李玫萱 Division of Thoracic Medicine
- Ying-Ming Tsai Tsai Division of Thoracic Medicine
- Jen-Yu Hung Division of Thoracic Medicine
- Inn-Wen Chong Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林俊維 Division of Thoracic Medicine
- 張竣期 Division of Thoracic Medicine
- 詹博強 Division of Thoracic Medicine
- 林明泰 Division of Thoracic Medicine
- 紀炳銓 Division of Thoracic Medicine
- 葉金水 Division of Thoracic Medicine
- 林慶雄 Division of Thoracic Medicine
- 陳正雄 Division of Thoracic Medicine
- 蔡偉宏 Division of Thoracic Medicine
- 施穎銘 Division of Thoracic Medicine
- 黃國揚 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林宗哲 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- 吳尚俊 Division of General Internal Medicine
- JIN-YUAN SHIH Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jih-Hsiang Lee
- JIN-YUAN SHIH Division of General Internal Medicine
- 陳冠宇 Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 許嘉林 Division of General Internal Medicine
- 廖斌志
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 林宗哲 Division of Hematology & Oncology
- 徐偉勛
- 楊景堯 Division of General Internal Medicine
- Chong-Jen Yu Division of General Internal Medicine
- YEN-TING LIN
- WEI-LI MA
- 廖唯昱 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
28 participants
-
Global
378 participants
